七叶皂苷C
|
|
|
- CAS号:
- 158732-55-9
- 英文名:
- escin IIa
- 英文别名:
- AESCIN IIA;EscinIC;escin IIa;82XHO27XQ8;b-D-Glucopyranosiduronic acid, (3b,4b,16a,21b,22a)-22-(acetyloxy)-16,23,28-trihydroxy-21-[[(2E)-2-methyl-1-oxo-2-buten-1-yl]oxy]olean-12-en-3-ylO-b-D-glucopyranosyl-(14)-O-[b-D-xylopyranosyl-(12)]-;β-D-Glucopyranosiduronic acid, (3β,4β,16α,21β,22α)-22-(acetyloxy)-16,23,28-trihydroxy-21-[[(2E)-2-methyl-1-oxo-2-buten-1-yl]oxy]olean-12-en-3-yl O-β-D-glucopyranosyl-(1→4)-O-[β-D-xylopyranosyl-(1→2)]-
- 中文名:
- 七叶皂苷C
- 中文别名:
- 七叶皂苷C;七叶皂苷 IIA
- CBNumber:
- CB81399174
- 分子式:
- C54H84O23
- 分子量:
- 1101.24
- MOL File:
- 158732-55-9.mol
|
|
|
七叶皂苷C化学性质
-
沸点:
-
1111.9±65.0 °C(Predicted)
-
|
-
密度:
-
1.45±0.1 g/cm3 (20 ºC 760 Torr)
-
|
-
酸度系数(pKa):
-
2.63±0.70(Predicted)
-
|
七叶皂苷C性质、用途与生产工艺
Escin IIa 是从七叶树种子七叶树中分离出来的，对动物急性炎症有积极作用。Escin IIa 对乙醇诱导的胃粘膜损伤有明显的保护作用。
Escins Ia, Ib, IIa, and IIb (50-200 mg/kg) inhibits the increase of vascular permeability induced by both acetic acid in mice and histamine in rats. Escins Ib, IIa, and IIb (50-200 mg/kg) also inhibit that induced by serotonin in rats, but escin Ia didn't. Escins Ia, Ib, IIa, and IIb (200 mg/kg) inhibit the hind paw edema induced by carrageenin at the first phase in rats. Escin Ia (200 mg/kg) and escins Ib, IIa, and IIb (50-200 mg/kg) inhibit the scratching behavior induced by compound 48/80 in mice, but escin Ia was weakest.
Escin IIa (10-50 mg/kg;p.o.;) potently inhibits ethanol-induced gastric mucosal lesions.
|
Animal Model:
|
Male Sprague–Dawley rats (Ethanol-induced gastric mucosal lesions in rats)
|
|
Dosage:
|
10-50 mg/kg
|
|
Administration:
|
p.o.
|
|
Result:
|
Showed a potent protective effect against ethanol-induced gastric lesions in rats.
|
七叶皂苷C
上下游产品信息
上游原料
下游产品
158732-55-9, 七叶皂苷C 相关搜索:
- standardized herbal extract
- reference standards from Chinese medicinal herbs (TCM).
- phytochemical
- pharmaceutical intermediate
- chemical reagent
- 标准品 -中药标准品
- 标准品-中药标准品
- 植物提取物
- 中药对照品
- 对照品
- 标准品
- 七叶皂苷 IIA
- 七叶皂苷C
- 158732-55-9
- AESCIN IIA
- EscinIC
- β-D-Glucopyranosiduronic acid, (3β,4β,16α,21β,22α)-22-(acetyloxy)-16,23,28-trihydroxy-21-[[(2E)-2-methyl-1-oxo-2-buten-1-yl]oxy]olean-12-en-3-yl O-β-D-glucopyranosyl-(1→4)-O-[β-D-xylopyranosyl-(1→2)]-
- b-D-Glucopyranosiduronic acid, (3b,4b,16a,21b,22a)-22-(acetyloxy)-16,23,28-trihydroxy-21-[[(2E)-2-methyl-1-oxo-2-buten-1-yl]oxy]olean-12-en-3-ylO-b-D-glucopyranosyl-(14)-O-[b-D-xylopyranosyl-(12)]-
- 82XHO27XQ8
- escin IIa